BWAY BrainsWay Ltd. - American Depositary Shares
NASDAQ · Health Care · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Abr 20, 2026BWAY Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
BWAY Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 4 de marzo de 2026 | 2-for-1 | Adelante |
| 3 de marzo de 2026 | 2-for-1 | Adelante |
Acerca de BrainsWay Ltd. - American Depositary Shares Descripción general de la empresa de Wikipedia
BrainsWay Ltd. (Hebrew: בריינסוויי) is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation (Deep TMS) as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem.
## History
The magnetic coil technology used by BrainsWay's devices, called the "H coil", emerged from research done in the late 1990s and early 2000s at the U.S. National Institutes of Health (NIH) by Abraham Zangen, Roy A. Wise, Mark Hallett, Pedro C. Miranda and Yiftach Roth. Most coils used in transcranial magnetic stimulation (TMS) provide a shallow magnetic field that affects neurons mostly on the surface of the brain, delivered with coil shaped like the number eight. The H coil provided magnetic fields deeper in the brain, and devices using them provide what is called "deep TMS".
The H-coil was patented by the NIH in 2002, and the procedure whereby the H-coil was applied to TMS became known as Deep TMS.
BrainsWay was founded in 2003 in Delaware by Uzi Sofer and Avner Hagai, together with David Zacut, and they set up a subsidiary in Jerusalem, and obtained an exclusive license from the NIH for the patent it filed on the H coil. By 2006 the company had conducted animal studies at Weizmann Institute of Science and had run its first clinical trial assessing safety, at Tel Aviv University.
In early 2007 BrainsWay executed an initial public offering on the Tel Aviv Stock Exchange, raising ₪33 million for a market cap of ₪110 million. In 2010 BrainsWay announced plans to list shares of the company's stock on the Nasdaq exchange but withdrew them in June.
In January 2013, BrainsWay received clearance from the U.S. Food and Drug Administration and from Health Canada to market its deep TMS device in the United States and in Canada as a treatment for treatment-resistant major depressive disorder. Evidence to support this use is tentative; as of 2013 no high quality evidence is available.
In August 2020, BrainsWay received FDA clearance for its deep TMS device for use in smoking addiction. The device has also previously been cleared by the FDA using an H1-coil for major depressive disorder and H7-coil for OCD.
In September 2025, BrainsWay received FDA clearance for an accelerated MDD protocol that shortens the initial treatment phase from 4 weeks down to just 6 days.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | BWAY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | 105.7promedio 5A ≈40.3 | ≈40.3 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | BWAY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Gross Margin (Margen Bruto) | 75.4%promedio 5A ≈75.1% | ≈75.1% | · | · | |
| Operating Margin (Margen Operativo) | 8.3%promedio 5A ≈-13.5% | ≈-13.5% | · | · | |
| EBITDA Margin (Margen EBITDA) | 8.3%promedio 5A ≈-13.5% | ≈-13.5% | · | · | |
| Pretax Margin (Margen antes de impuestos) | 14.8%promedio 5A ≈-11.8% | ≈-11.8% | · | · | |
| Net Profit Margin (Margen de Beneficio Neto) | 14.5%promedio 5A ≈-12.5% | ≈-12.5% | · | · | |
| ROA | 7.3%promedio 5A ≈-5.3% | ≈-5.3% | 9.7% | Débil | |
| ROE | 11.2%promedio 5A ≈-7.1% | ≈-7.1% | 12.3% | Débil | |
| ROIC | 5.8%promedio 5A ≈-8.5% | ≈-8.5% | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | BWAY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Current Ratio (Ratio corriente) | 3.7promedio 5A ≈5.8 | ≈5.8 | 5.6 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 3.0promedio 5A ≈2.9 | ≈2.9 | 4.5 | Baja liquidez | |
| Interest Coverage (Cobertura de Intereses) | 2.0promedio 5A ≈-6.5 | ≈-6.5 | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | BWAY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.5promedio 5A ≈0.5 | ≈0.5 | · | · | |
| Inventory Turnover (Rotación de Inventario) | 2.3promedio 5A ≈2.7 | ≈2.7 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$404.8K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | $0.21 | $0.15 | 36.5% | |
| 31 de marzo de 2026 | $0.19 | $0.17 | 7.0% | |
| 31 de diciembre de 2025 | $0.26 | $0.13 | 98.0% | |
| 30 de septiembre de 2025 | $0.13 | $0.10 | 35.6% | |
| 30 de junio de 2025 | $0.18 | $0.09 | 95.2% | |
| 31 de marzo de 2025 | $0.26 | $0.13 | 98.0% | |
| 31 de diciembre de 2024 | $0.15 | $0.08 | 93.2% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $52M | $41M | $32M | $27M | $30M | $22M | $23M | $16M | |
| Cost of Revenue | $13M | $10M | $8M | $7M | $7M | $5M | $5M | $4M | |
| Gross Profit | $39M | $31M | $23M | $20M | $23M | $17M | $18M | $13M | |
| R&D Expense | $10M | $7M | $7M | $8M | $6M | $6M | $8M | $6M | |
| SG&A Expense | $7M | $6M | $5M | $7M | $6M | $5M | $5M | $3M | |
| Operating Income | $4M | $1M | $-5M | $-13M | $-5M | $-5M | $-8M | $-5M | |
| Interest Expense | $2M | $2M | $1M | $1M | $-2M | $319.0K | $1M | $1M | |
| Interest Income | $6M | $4M | $2M | $1M | $255.0K | · | · | · | |
| Pretax Income | $8M | $3M | $-4M | $-13M | $-6M | $-5M | $-10M | $-6M | |
| Income Tax | $135.0K | $538.0K | $251.0K | $315.0K | $43.0K | $237.0K | $422.0K | $209.0K | |
| Net Income | $8M | $3M | $-4M | $-13M | $-6M | $-5M | $-10M | $-6M | |
| EPS (Basic) | $0.20 | $0.09 | $-0.13 | $-0.40 | $-0.21 | · | · | · | |
| EPS (Diluted) | $0.18 | $0.05 | $-0.13 | $-0.40 | $-0.21 | · | · | · | |
| Shares (Basic) | 38,005,251 | 33,969,077 | 33,155,669 | 32,980,997 | 31,154,258 | 22,453,025 | 20,506,202 | 16,640,446 | |
| EBITDA | $4M | $1M | $-5M | $-13M | $-5M | $-5M | $-8M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $68M | $69M | $35M | $48M | $17M | $17M | $22M | $9M | |
| Inventory | $7M | $4M | $4M | $4M | · | · | · | · | |
| Current Assets | $84M | $80M | $55M | $58M | $65M | $24M | $29M | $13M | |
| PP&E (Net) | · | · | · | · | · | $4M | $4M | $3M | |
| Total Assets | $113M | $94M | $63M | $64M | $76M | $34M | $39M | $24M | |
| Accounts Payable | $7M | $6M | $5M | $4M | $5M | $4M | $3M | $3M | |
| Current Liabilities | $22M | $15M | $10M | $8M | $9M | $7M | $7M | $8M | |
| Retained Earnings | $-91M | $-98M | $-101M | $-97M | $-84M | $-77M | $-72M | $-62M | |
| Stockholders' Equity | $73M | $62M | $42M | $45M | $57M | $20M | $24M | $7M |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $17M | $10M | $1M | $-10M | $884.0K | $-1M | $-7M | $-4M | |
| CapEx | · | · | · | · | $2M | $2M | $3M | $2M | |
| Investing Cash Flow | $-17M | $30M | $-37M | $42M | $-42M | $-2M | $-2M | $-1M | |
| Financing Cash Flow | $-2M | $18M | $-1M | $-2M | $42M | $-1M | $22M | $-265.0K | |
| Free Cash Flow | · | · | · | · | $-1M | $-4M | $-11M | · | |
| Levered FCF | · | · | · | · | $-3M | $-4M | $-12M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.4% | 74.6% | 73.9% | 73.8% | 77.8% | 77.1% | 77.8% | · | |
| Operating Margin | 8.3% | 3.4% | -15.6% | -46.7% | -16.9% | -21.9% | -36.7% | · | |
| Net Margin | 14.5% | 7.1% | -13.2% | -49.1% | -21.8% | -24.4% | -44.7% | · | |
| Pretax Margin | 14.8% | 8.4% | -12.4% | -48.0% | -21.6% | -23.3% | -42.9% | · | |
| EBITDA Margin | 8.3% | 3.4% | -15.6% | -46.7% | -16.9% | -21.9% | -36.7% | · | |
| ROA | 7.3% | 3.7% | -6.6% | -19.0% | -11.8% | -14.8% | -33.1% | · | |
| ROE | 11.2% | 5.6% | -9.7% | -26.0% | -16.8% | -24.6% | -66.3% | · | |
| ROIC | 5.8% | 1.9% | -12.7% | -28.6% | -8.8% | -25.7% | -36.5% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 5.2 | 5.7 | 7.1 | 7.2 | 3.6 | 4.3 | · | |
| Quick Ratio | 3.0 | · | 1.1 | 5.8 | 1.9 | 2.5 | 3.2 | · | |
| Interest Coverage | 2.0 | 0.9 | 4.3 | -36.1 | -3.5 | -15.1 | -5.9 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.6 | 0.7 | · | |
| Inventory Turnover | 2.3 | 2.6 | 2.2 | 3.7 | · | · | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | $0.18 | $0.05 | $-0.13 | $-0.40 | $-0.21 | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $52M | $41M | $32M | $27M | $30M | $22M | $23M | · | |
| Net Income TTM | $8M | $3M | $-4M | $-13M | $-6M | $-5M | $-10M | · | |
| P/E | 105.7 | 188.6 | -49.8 | -6.2 | -36.7 | · | · | · | |
| Earnings Yield | 0.95% | 0.53% | -2.0% | -16.2% | -2.7% | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q4 2020 |
|---|---|---|
| Revenue TTM | $22M | |
| Net Income TTM | $-5M |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $52M | $41M | $32M | $27M | $30M |
| Margen Bruto % | 75.4% | 74.6% | 73.9% | 73.8% | 77.8% |
| Margen Operativo % | 8.3% | 3.4% | -15.6% | -46.7% | -16.9% |
| Beneficio neto | $8M | $3M | $-4M | $-13M | $-6M |
| EPS Diluido | $0.18 | $0.05 | $-0.13 | $-0.40 | $-0.21 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 3.7 | 5.2 | 5.7 | 7.1 | 7.2 |
| Ratio Rápido | 3.0 | · | 1.1 | 5.8 | 1.9 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | · | · | · | $-1M |
Propietarios institucionales (13F) 56 declarantes · $160.8M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 8 (-12 vs trimestre anterior) | 8 (+1 vs trimestre anterior) | 13 (-18 vs trimestre anterior) | 19 (+16 vs trimestre anterior) | -375K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Valor Management LLC | $82 434 875 | 5 314 950 | 51,27% | Acciones |
| MASTERS CAPITAL MANAGEMENT LLC | $23 265 000 | 1 500 000 | 14,47% | Acciones |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $9 191 319 | 592 606 | 5,72% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $7 381 519 | 475 920 | 4,59% | Acciones |
| Cresset Asset Management, LLC | $4 884 471 | 314 924 | 3,04% | Acciones |
| Y.D. More Investments Ltd | $3 682 586 | 237 433 | 2,29% | Acciones |
| MORGAN STANLEY | $2 930 893 | 188 968 | 1,82% | Acciones |
| EAGLE GLOBAL ADVISORS LLC | $2 832 219 | 182 606 | 1,76% | Acciones |
| ARK Investment Management LLC | $2 210 175 | 142 500 | 1,37% | Acciones |
| SEI INVESTMENTS CO | $1 856 811 | 119 717 | 1,15% | Acciones |
| UBS Group AG | $1 567 704 | 101 077 | 0,98% | Acciones |
| Sigma Planning Corp | $1 557 747 | 100 435 | 0,97% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $1 543 943 | 99 545 | 0,96% | Acciones |
| ROYCE & ASSOCIATES LP | $1 504 982 | 97 033 | 0,94% | Acciones |
| JPMORGAN CHASE & CO | $1 468 562 | 96 807 | 0,91% | Acciones |
| TWO SIGMA ADVISERS, LP | $1 460 736 | 76 800 | 0,91% | Acciones |
| GOLDMAN SACHS GROUP INC | $1 428 331 | 92 091 | 0,89% | Acciones |
| Huntleigh Advisors, Inc. | $1 354 120 | 87 306 | 0,84% | Acciones |
| Quadrature Capital Ltd | $978 588 | 63 094 | 0,61% | Acciones |
| WELLS FARGO & COMPANY/MN | $862 806 | 55 629 | 0,54% | Acciones |
| CITADEL ADVISORS LLC | $737 020 | 47 519 | 0,46% | Acciones |
| State of Wyoming | $600 935 | 38 745 | 0,37% | Acciones |
| RHUMBLINE ADVISERS | $581 753 | 37 509 | 0,36% | Acciones |
| Trexquant Investment LP | $572 195 | 36 892 | 0,36% | Acciones |
| Man Group plc | $426 122 | 27 474 | 0,27% | Acciones |
| Crossmark Global Holdings, Inc. | $393 194 | 25 351 | 0,24% | Acciones |
| Voleon Capital Management LP | $384 819 | 24 811 | 0,24% | Acciones |
| Good Life Advisors, LLC | $360 310 | 27 400 | 0,22% | Acciones |
| NewEdge Advisors, LLC | $292 055 | 18 830 | 0,18% | Acciones |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | $270 960 | 17 470 | 0,17% | Acciones |
| Engineers Gate Manager LP | $267 610 | 17 254 | 0,17% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $255 729 | 16 488 | 0,16% | Acciones |
| ROYAL BANK OF CANADA | $232 000 | 14 940 | 0,14% | Acciones |
| Aquatic Capital Management LLC | $224 709 | 14 488 | 0,14% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $212 564 | 13 705 | 0,13% | Acciones |
| CITADEL ADVISORS LLC | $170 610 | 11 000 | 0,11% | Opción de compra |
| State of Tennessee, Department of Treasury | $136 675 | 8 812 | 0,09% | Acciones |
| OSAIC HOLDINGS, INC. | $70 848 | 4 568 | 0,04% | Acciones |
| GAMMA Investing LLC | $56 363 | 3 634 | 0,04% | Acciones |
| BlackRock, Inc. | $26 119 | 1 684 | 0,02% | Acciones |
| BARCLAYS PLC | $22 257 | 1 435 | 0,01% | Acciones |
| TD Waterhouse Canada Inc. | $21 765 | 1 430 | 0,01% | Acciones |
| LANARK FINANCIAL, INC. | $17 061 | 1 100 | 0,01% | Acciones |
| ACADIAN ASSET MANAGEMENT LLC | $12 514 | 807 931 | 0,01% | Acciones |
| Basepoint Wealth LLC | $9 306 | 600 | 0,01% | Acciones |
| Russell Investments Group, Ltd. | $6 049 | 390 | 0,00% | Acciones |
| NISA INVESTMENT ADVISORS, LLC | $5 196 | 335 | 0,00% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $2 679 | 185 | 0,00% | Acciones |
| Stone House Investment Management, LLC | $2 032 | 131 | 0,00% | Acciones |
| Steigerwald, Gordon & Koch Inc. | $1 861 | 120 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Valor BrainsWay Holdings, LLC, Valor Siren Ventures II L.P., Valor Siren Partners II-A L.P., Valor Siren Partners II-B L.P., Valor SV Associates II L.P., Valor SV Capital II LLC, Valor Management L.P., Valor Management LLC, Valor Funds Group LLC, Jonathan Shulkin, Antonio Gracias ×3 presentaciones | 8 de octubre de 2025 | 15,00% | Enmienda | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 3 insiders · 2 directivos · 1 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Yiftach Roth | Chief Scientist | 2 de junio de 2026 S | 1 072 305 | 0 | 0 | $0 |
| Gilad Moiseyev | Chief Technology Officer | 25 de mayo de 2026 M | 53 098 | 0 | 0 | $0 |
| Rayten Michal Ety Mitrany | Consejero | 26 de mayo de 2026 S | 12 500 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 3 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
BWAY Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
Precio objetivo a 12 meses
3 analistas · 2026-10-03Objetivo medio $19.27 +54,1%
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.